Gainesville, FL, United States of America

Daniela Carmen Oniciu

This inventor holds 16 USPTO granted patents and 14 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Espervita Therapeutics, Inc., Esperion Therapeutics, Inc., Ocuphire Pharma, Inc.. Active years: 2007-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniela Carmen Oniciu. Retrieved from https://idiyas.com/inventor/daniela-carmen-oniciu-ljpxbn7r

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16 (Patent Applications = 14)

% Patents Active = 93.8

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 1.5

ph-index = 5

Forward Citations = 101(Granted Patents)

Location History:

Ann Arbor, MI (US) (2011)
Vielle-Toulouse, FR (2011)
Gainesville, FL (US) (2007 - 2024)

Company Filing History:

8 out of 8

Espervita Therapeutics, Inc.

patents

3 out of 60

Esperion Therapeutics, Inc.

patents

2 out of 11

Ocuphire Pharma, Inc.

Neurobo Pharmaceuticals, Inc.

patents

Years Active: 2007-2026

Loading Chart...

Areas of Expertise:

Phentolamine Mesylate

Cholesterol Management

Functionalized Acids

Therapeutic Uses

Pharmaceutical Compositions

Long-Chain Hydrocarbons

Disease Prevention

Salts and Esters

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12735389 - Highly pure phentolamine mesylate and methods for making same (2026-09-15),

2. 12503422 - GEMCABENE, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR (2025-12-23),

3. 12396972 - Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of disease (2025-08-26),

4. 12312308 - Salts and esters of APX3330 and therapeutic uses thereof (2025-05-27),

5. 12252467 - Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of disease (2025-03-18),

6. 12180151 - Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of disease (2024-12-31),

7. 11976044 - Highly pure phentolamine mesylate (2024-05-07),

8. 11737995 - Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of disease (2023-08-29),

9. 11730712 - Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of disease (2023-08-22),

10. 11566005 - Highly pure phentolamine mesylate and methods for making same (2023-01-31),

11. 11267778 - Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of disease (2022-03-08),

12. 11098002 - Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of disease (2021-08-24),

13. 11084773 - Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of disease (2021-08-10),

14. 8084498 - Ketone compounds and compositions for cholesterol management and related uses (2011-12-27),

15. 8067466 - Cycloalkyl-hydroxyl compounds and compositions for cholesterol management (2011-11-29),

Title: The Innovative Contributions of Daniela Carmen Oniciu

Introduction

Daniela Carmen Oniciu is a prominent inventor based in Gainesville, FL (US). She has made significant contributions to the field of pharmaceuticals, holding a total of 14 patents. Her work focuses on developing compounds that address various health issues, particularly kidney diseases and fibrosis.

Latest Patents

Among her latest patents is the invention of functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof. This invention provides methods for treating or preventing kidney diseases and fibrosis, including chronic kidney disease (CKD), kidney fibrosis, heart fibrosis, uterine fibrosis, and cystic fibrosis. The compounds involved are detailed in various formulae and include pharmaceutically acceptable salts and solvates. Another notable patent is related to salts and esters of APX3330, which includes therapeutic uses for treating diseases such as cancer, liver disorders, ocular disorders, cardiovascular disorders, fibrosis, and inflammatory disorders. This invention also encompasses compositions comprising these compounds and methods for their effective administration.

Career Highlights

Throughout her career, Daniela has worked with notable companies such as Espervita Therapeutics, Inc. and Esperion Therapeutics, Inc. Her innovative work has positioned her as a key figure in the pharmaceutical industry, contributing to advancements in treatment methodologies.

Collaborations

Daniela has collaborated with esteemed colleagues, including Jean-Louis Henri Dasseux and Gregory R. Steinberg. These partnerships have further enhanced her research and development efforts in the field.

Conclusion

Daniela Carmen Oniciu's contributions to innovation in pharmaceuticals are noteworthy. Her extensive patent portfolio reflects her commitment to improving health outcomes through scientific advancements.

Profile summary based on public USPTO records.